AMN Healthcare/$AMN
1D1W1MYTD1Y5YMAX
Capital at risk
About AMN Healthcare
AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.
- Ticker
- $AMN
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 2,664
- Headquarters
- Dallas, United States
- Website
- www.amnhealthcare.com
AMN Healthcare Metrics
BasicAdvanced
$1.3B
12.39
$2.69
0.39
-
Price and volume
Market cap
$1.3B
Beta
0.39
52-week high
$37.22
52-week low
$14.97
Average daily volume
681K
Financial strength
Current ratio
1.128
Quick ratio
1.027
Long term debt to equity
1.039
Total debt to equity
1.047
Interest coverage (TTM)
4.51%
Profitability
EBITDA (TTM)
307.293
Gross margin (TTM)
27.79%
Net profit margin (TTM)
3.05%
Operating margin (TTM)
4.68%
Effective tax rate (TTM)
36.10%
Revenue per employee (TTM)
$1,290,000
Management effectiveness
Return on assets (TTM)
4.39%
Return on equity (TTM)
15.56%
Valuation
Price to earnings (TTM)
12.388
Price to revenue (TTM)
0.377
Price to book
1.74
Price to tangible book (TTM)
-4.86
Price to free cash flow (TTM)
2.951
Free cash flow yield (TTM)
33.89%
Free cash flow per share (TTM)
11.299
Growth
Revenue change (TTM)
23.99%
Earnings per share change (TTM)
-134.58%
3-year revenue growth (CAGR)
-7.80%
10-year revenue growth (CAGR)
7.12%
3-year earnings per share growth (CAGR)
-29.19%
10-year earnings per share growth (CAGR)
2.24%
What the Analysts think about AMN Healthcare
Analyst ratings (Buy, Hold, Sell) for AMN Healthcare stock.
Analyst projections of the future price of AMN Healthcare stock.
Bulls say / Bears say
Q2 2026 revenue of $673.2 million and adjusted EPS of $0.77 significantly exceeded the company’s guidance of $620 million–$635 million and analyst estimates of ~$0.19 per share, driven by strong travel nurse and allied staffing demand. (SEC Q2 Results) (SEC Q1 8-K Guidance)
The acquisitions of Jaide Health in June 2026 and the ESSENTIAL Leadership Assessment platform in June 2026 expand AMN’s AI-enabled medical interpretation and leadership advisory offerings, positioning the company to capture higher-margin, technology-driven growth opportunities. (PRNewswire) (PRNewswire)
A white paper published on August 12, 2026 projects persistent workforce strain across nursing, allied health, and physician segments through 2030, underscoring sustained demand tailwinds for AMN’s core staffing solutions. (PRNewswire)
The Physician and Leadership Solutions segment reported revenue of $165 million, down 6% year-over-year and flat sequentially in Q2 2026, highlighting ongoing weakness in higher-margin physician staffing demand. (PRNewswire)
AMN’s 2026 annual report warns that clients’ adoption of advanced AI-driven staffing management and sophisticated internal recruiting processes may reduce demand for third-party staffing services, posing a risk to future revenue growth. (SEC Annual Report)
A Reuters brief on March 30, 2026 noted that integrated physician staffing strategies can cut premium labor spend by 22%, underscoring healthcare providers’ ability to internally reduce reliance on AMN’s higher-margin services. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2026.
AMN Healthcare Financial Performance
Revenues and expenses
AMN Healthcare Earnings Performance
Company profitability
Upcoming events
No upcoming events
AMN Healthcare News
AllArticlesVideos
Funds containing AMN Healthcare
AllEURUSDGBP
Fund name | Fund size | $AMN weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.12% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.08% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.08% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.04% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.